– Solid Biosciences to collaborate with Mayo Clinic’s genetic cardiology disease laboratory –
Other News
Maze Therapeutics Announces Oversubscribed $115 Million Financing to Support Advancement of Clinical-Stage Programs and Future Pipeline
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and metabolic diseases, today announced the completion of a $115 million Series D financing that included the conversion of issued convertible […]
Two-Year Data Proves Vista Cardiac Delivers Faster, More Reliable MRI Scans
PALO ALTO, Calif.–(BUSINESS WIRE)–Vista, a leader in intelligent MRI acquisition software, today announced two-year clinical results showing Vista Cardiac significantly improves workflow efficiency, ensures high-quality and consistent imaging, and scales cardiac MRI (CMR) programs to expand access to more patients. “We’re pleased with the strong data from Brigham and Women’s Hospital validating […]
New Technology from Riverain Adds Coronary Artery Calcification Scoring to Ungated Chest CT Scans
Incidental CAC Scores Now Possible with ClearRead™ CT MIAMISBURG, Ohio, Dec. 3, 2024 /PRNewswire/ — Coronary artery calcification (CAC) affects 20 million Americans annually, and over half of the incidental findings go unreported.* New FDA-cleared technology from Riverain can provide a…
Philips aims to advance cardiac MRI technology through AI-driven research
December 3, 2024
Biotricity Achieves Positive Free Cash Flow Milestone
First Time in the Company’s History REDWOOD CITY, Calif., Dec. 3, 2024 /PRNewswire/ — Biotricity Inc. (OTCQB: BTCY) (“Biotricity” or the “Company”), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced achieving…
A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter Technology
BTL, a leader in medical innovation, is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next-generation catheter designed to improve the way AF is treated. PRAGUE, Dec. 3, 2024…
Manipal Hospitals successfully performs Eastern India’s first AI-powered injectable wireless pacemaker insertion
KOLKATA, India, Dec. 3, 2024 /PRNewswire/ — Marking a transformative milestone in cardiac care, Manipal Hospitals, one of the largest healthcare networks in India announced the successful insertion of an AI-driven, wireless injectable pacemaker. The Aveir Leadless pacemaker by Abbott,…
Inari Medical Announces Joint Venture in Greater China
IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced it has entered into a joint venture with 6 Dimensions Capital (“6 Dimensions”) and its successor fund 120 Capital, and VFLO Medical (“VFLO”), a medical device platform incubated by 6 Dimensions and 120 Capital, to provide access to Inari’s innovative technology for patients with significant unmet needs in Greater China.
Mindray Unveils the Future of Medical Imaging with the Expansion of its Radiology Portfolio
Mindray Sets a New Standard with its Resona-Series Ultrasound Machines and Upcoming Expansion into Digital Radiography MAHWAH, N.J., Dec. 2, 2024 /PRNewswire/ — Mindray, a leading global developer of healthcare technologies and solutions specializing in patient monitoring, anesthesia,…
